scispace - formally typeset
J

Joseph A. Kufera

Researcher at University of Maryland, Baltimore

Publications -  98
Citations -  4964

Joseph A. Kufera is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Poison control & Population. The author has an hindex of 35, co-authored 91 publications receiving 4616 citations. Previous affiliations of Joseph A. Kufera include University of Maryland Medical System.

Papers
More filters
Journal ArticleDOI

Necrotizing soft tissue infections. Risk factors for mortality and strategies for management.

TL;DR: Necrotizing soft tissue infections represent a group of highly lethal infections best treated by early and repeated extensive debridement and broad-spectrum antibiotics and Hyperbaric oxygen appears to offer the advantage of early wound closure.
Journal ArticleDOI

Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus: Early Treatment Diabetic Retinopathy Study Report 14

Aaron Kassoff, +147 more
- 09 Sep 1992 - 
TL;DR: The early treatment diabetic retinopathy study (ETDRS) as mentioned in this paper was a randomized clinical trial of aspirin vs placebo, which was sponsored by the National Eye Institute (NIEI).
Journal ArticleDOI

The microbiology of necrotizing soft tissue infections.

TL;DR: NSTI are frequently polymicrobial and initial antibiotic coverage with a broad-spectrum regimen is warranted, and the initial regimen should include agents effective against aerobic gram-positive cocci, gram-negative rods, and a variety of anaerobes.
Journal ArticleDOI

Early predictors of postconcussive syndrome in a population of trauma patients with mild traumatic brain injury

TL;DR: After MTBI, anxiety among women and NS are important predictors of PCS, and other physical symptoms, while more prevalent, are poor predictorsOf PCS.
Journal ArticleDOI

Association between early hyperoxia and worse outcomes after traumatic brain injury.

TL;DR: Hyperoxia and hypoxia were found to be equally detrimental to short-term outcomes in patients with TBI and a narrower therapeutic window for oxygenation may improve mortality and functional outcomes.